• Corpus ID: 23506517

Management of chronic allograft dysfunction by switch over to rapamycin.

@article{Sundaram2010ManagementOC,
  title={Management of chronic allograft dysfunction by switch over to rapamycin.},
  author={Varun Sundaram and Georgi Abraham and Nusrath Fathima and Vivek Sundaram and Yogesh N.V. Reddy and Milly Mathew and Vijaiaboobbathi Sathiah},
  journal={Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia},
  year={2010},
  volume={21 1},
  pages={
          37-42
        }
}
  • V. Sundaram, G. Abraham, V. Sathiah
  • Published 2010
  • Medicine
  • Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia
The aim of this study was to evaluate the efficacy of conversion from calcineurin inhibitors (CNI)-based to a rapamycin-based immunosuppressive regimen in renal transplant recipients who had allograft dysfunction, in a South Indian population. We analyzed the results of 75 (19.5%) of the 398 renal transplants performed over a five-year period from 2002 to 2007, who were converted from a CNI-based immunosuppression to rapamycin including patients with chronic allograft dysfunction, chronic… 
Long-term results of conversion from calcineurin inhibitors to sirolimus in 150 maintenance kidney transplant patients.
  • C. GarrousteN. Kamar L. Rostaing
  • Medicine, Biology
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
  • 2012
TLDR
Conversion of calcineurin inhibitors to sirolimus in kidney transplant recipients was associated with improved renal function and the reintroduction of calcinesporine versus tacrolimus was safe in patients who were withdrawn from siro Limus owing to adverse effects.
Evolution of deceased-donor transplantation in India with decline of commercial transplantation: a lesson for developing countries
TLDR
The positive impact of a structured deceased-donor program has resulted in a reduction in the number of commercial transplantation operations taking place in India, and generic immunosuppressive drugs manufactured by the local pharmaceutical industry have been shown to be noninferior, and have greatly reduced the cost of achieving Immunosuppression.
Clinical application of mTORi based immunosuppression for renal transplantation in India
  • B. Chacko
  • Medicine
    Clinical transplantation
  • 2012
TLDR
A clinical application of mTORi based immunosuppression for renal transplantation in India and its application in India shows promising results.